financetom
CRVO
financetom
/
Healthcare
/
CRVO
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
CervoMed Inc.CRVO
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.

It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery.

The company is based in Boston, Massachusetts.

Latest News >
Dogecoin Price Prediction: Is a Parabolic DOGE Bull Run in the Making?
Dogecoin Price Prediction: Is a Parabolic DOGE Bull Run in the Making?
Apr 1, 2024
Dogecoin (DOGE), the first meme coin in the crypto industry, made a huge comeback last week when it crossed the $0.22 mark —a price not seen since November 2021. Data from CoinGecko shows that DOGE’s price has increased 22.3% weekly, and its trading volume has increased more than 50% to 3.17 billion. DOGE is currently trading at $0.20. Its market...
Research Alert: CFRA Raises Opinion On Industrials To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Industrials To Marketweight From Underweight
Apr 1, 2024
10:25 AM EDT, 04/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: The sector has experienced an improvement in absolute and relative price performance due to the expectation that interest rate cuts, as well as continued progress on inventory reductions, will likely...
China's forecast-beating economic data buys officials time to figure out fix
China's forecast-beating economic data buys officials time to figure out fix
Apr 1, 2024
BEIJING (Reuters) - China's $18.6 trillion economy has skirted some near-term downside risks as suggested by recent indicators, analysts said, buying officials more time to convince investors they can fire up a new growth engine for 2024 and the years ahead. Economic data over the January-February period and a factory owners survey for March offered relief to Chinese policymakers seeking...
Moody's Downgrades Ratings on Enbridge, 3 Subsidiaries; Changes Outlook to Stable
Moody's Downgrades Ratings on Enbridge, 3 Subsidiaries; Changes Outlook to Stable
Apr 1, 2024
10:17 AM EDT, 04/01/2024 (MT Newswires) -- Moody's said Friday that it has downgraded the senior unsecured ratings of Enbridge Inc. ( ENB ) and its subsidiaries Enbridge Energy Partners LP, Enbridge Energy Limited Partnership, and Spectra Energy Partners LP to Baa2 from Baa1. Additionally, the rating agency downgraded the senior unsecured rating of Texas Eastern Transmission LP to Baa1...
Copyright 2023-2025 - www.financetom.com All Rights Reserved